docetaxel,pembrolizumab
merck
['crpc', 'docetaxel', 'key,note,921', 'pembro']
an amazing conferece by md petrylak with keynote-921 study: pembrolizumab + docetaxel for pts with mcrpc where the addition of them did not significantly improve rpfs or os for pts with mcrpc and did not result in a notable increase in treatment-related aes. #ascogu2023 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.